🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Functional and Aesthetic Outcomes Following Lower Lip Reconstruction

Recruitingn/aAges any - anyAllHôpital NOVO
NCT07298070 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This retrospective study, aims to evaluate the functional and aesthetic results of lower lip reconstructions, incorporating both patient experiences and the analysis of physicians and surgeons working on facial issues (plastic surgeons and dermatologists) in order to optimize future therapeutic strategies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient over 18 years of age. * Patients who underwent lower lip reconstruction after excision for skin carcinoma, operated on in Pontoise between January 1, 2014, and October 31, 2025. * Patients who had a post-operative follow-up consultation (± 2 months). * Patients who were informed and did not object to participating in the study Exclusion Criteria: * Cognitive impairment preventing completion of the questionnaire. * Patient under legal protection (guardianship, conservatorship, or judicial protection). * Patient deceased.
💊

What it tests

  • Patient-Reported Outcome Questionnaire (post-operative)
📍

Where

1 site
Hôpital NOVO
Cergy-Pontoise, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy